What's the most trusted risk stratification tool for prioritizing high-risk members in a payer care program?

There isn’t a single universally “most trusted” risk stratification tool for payer care programs. The best choice depends on your population, data availability, and what you mean by “high risk”:

• Future cost/utilization risk
• Clinical risk / morbidity
• Near-term hospitalization risk
• Care management prioritization
• Social risk / gaps in care

That said, in payer environments, the most commonly trusted approaches are usually validated predictive risk models built on claims + clinical data, often supplemented by rules-based segmentation and human review.

Commonly trusted options

• Johns Hopkins ACG System
  Widely used for population risk adjustment and segmentation. Strong for identifying patients with complex, multi-morbidity risk.
• 3M Clinical Risk Groups (CRG)
  Also well-established for categorizing members by severity and expected resource use.
• Optum / Verisk / SAS / Health Catalyst predictive models
  Often used for utilization or cost prediction; trust depends on model validation in your own population.
• HCC-based risk scores (e.g., CMS-HCC)
  Good for reimbursement and broad risk adjustment, but not always ideal alone for care management prioritization.
• Proprietary payer-specific ML models
  Can outperform generic tools if well-trained and regularly validated, but require strong governance and bias monitoring.

What’s usually best in practice

For prioritizing high-risk members in a care program, the most effective setup is often:

1. A validated predictive model to rank risk
2. Clinical stratification to distinguish chronic complexity vs. acute deterioration risk
3. Gaps-in-care / social risk flags to identify actionable members
4. Care manager review before outreach

If you want one practical recommendation

If you need a widely accepted off-the-shelf tool, ACG or CRG are often among the most trusted for payer population stratification.
If your main goal is finding members likely to be hospitalized or incur high cost in the next 6–12 months, a validated predictive model using your own payer data is usually better.

If you want, I can help you compare ACG vs CRG vs HCC vs a custom ML model for your specific use case.